Extracellular Vesicle-Associated IL4 Displays Enhanced Anti-Inflammatory Properties in Microglial Cells.

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Neuroinflammation and neurodegeneration are linked to microglial dysfunction in the central nervous system (CNS).
• Interleukin-4 (IL4) shows promise in restoring microglial homeostasis in CNS injury models, but optimal delivery is unclear.

Purpose of the Study:

• To investigate if extracellular vesicles (EVs) expressing IL4 can improve the anti-inflammatory effects of IL4 on microglia.
• To compare the efficacy of IL4 delivered via EVs versus soluble IL4 in a murine microglial model.

Main Methods:

• Engineered murine microglia (BV2 cells) constitutively expressing IL4 were used to generate IL4-carrying EVs.
• Wild-type BV2 cells were treated with IL4-EVs or soluble IL4 to assess anti-inflammatory responses via IL4R signaling.
• Experiments included blocking IL4 with antibodies and knocking out the IL4 receptor alpha subunit to elucidate the mechanism of action.

Main Results:

• IL4-EVs induced a faster and enhanced anti-inflammatory phenotype in BV2 cells compared to soluble IL4.
• The effect of IL4-EVs was IL4-dependent but did not require co-delivery of the IL4 receptor.
• IL4-EVs led to prolonged IL4 receptor permanence in early endosomes, suggesting amplified signaling.

Conclusions:

• IL4 associated with microglia-derived EVs enhances its anti-inflammatory efficacy in an in vitro murine microglial model.
• This finding suggests a potential novel therapeutic strategy using IL4-loaded EVs to restore microglial function in neuroinflammatory human disorders.